July 1, 2026 · Form 4 insider transaction
Griffiths Richard Ian bought 79,180 shares of Silence Therapeutics plc, a transaction worth N/A. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 6 days after the transaction.
Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.; The securities were sold by Cream Capital Limited ("CCL") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.